<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0407B94D-DABF-4B46-B5F0-2CBDC1C63C67"><gtr:id>0407B94D-DABF-4B46-B5F0-2CBDC1C63C67</gtr:id><gtr:name>national Institute on Aging</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Medical and Human Sciences</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0407B94D-DABF-4B46-B5F0-2CBDC1C63C67"><gtr:id>0407B94D-DABF-4B46-B5F0-2CBDC1C63C67</gtr:id><gtr:name>national Institute on Aging</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/85C71D88-B807-463D-A3B9-405F82E74D39"><gtr:id>85C71D88-B807-463D-A3B9-405F82E74D39</gtr:id><gtr:firstName>Stuart</gtr:firstName><gtr:surname>Pickering-Brown</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0701441"><gtr:id>69B7BA9A-9A4E-4F76-9C68-8F58289F3D0C</gtr:id><gtr:title>Molecular Investigations of Frontotemporal Lobar Degeneration</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0701441</gtr:grantReference><gtr:abstractText>Approximately 750,000 people in the UK have dementia, the most common and widely known is Alzheimer?s disease. The second most common form of dementia is called frontotemporal lobar degeneration (FTLD). We know around 5% of cases of FTLD are caused by errors in a gene called tau and another 5% is caused by errors in a gene called progranulin. There is an unknown gene on chromosome 9 that can cause FTLD and motor neuron disease. We believe we have now identified this gene (called UBAP1) and experiments we have done suggest it maybe important in regulating the amount of tau and progranulin in the brain therefore linking all this genes into a common pathway. As little is known about the functions of UBAP1 or progranulin in the brain we propose study the effects of progranulin on cells and characterise the distribution and function of UBAP1 and explore how it controls the levels of tau and progranulin. This work will help us to gain understanding to the biological problems causing FTLD. This knowledge will help in diagnosis and in the development of systems to produce a treatment, ultimately helping people with FTLD.</gtr:abstractText><gtr:technicalSummary>Neurodegenerative diseases of our progressively more aged society are becoming an increasing social and economic burden. Frontotemporal lobar degeneration (FTLD) is the second most common form of dementia after Alzheimer?s disease. Up to 40% of patients have a family history of this disease indicating a large genetic component to its aetiology. Approximately 5% of cases are caused by mutations in the MAPT gene encoding the microtubule associated protein, tau. Patients with MAPT mutations display a prominent tau-based neuropathology at autopsy. Around a further 5% of cases are caused by null-mutations of the pleiotropic growth factor, progranulin (PGRN) and the neuropathological features of these comprise of neuronal inclusions containing ubiquitinated TDP-43 protein. Until the discovery of mutations in PGRN very little was known about the function of this protein in the CNS. Preliminary data: Using linkage disequilibrium mapping of the recently reported FTLD ch9p linkage region, we identified genetic association of UBAP1 (Ubiquitin Associated Protein 1) within our FTLD cohort (214 patients, 286 controls; MAPT and PGRN mutation -ve). Analysis revealed SNPs/haplotypes were consistently associated with a maximum OR of 1.71 (95% CI 1.20-2.44, P=0.003). Crucially, we successfully replicated this association in a Dutch FTLD cohort (230 FTLD cases, 484 controls) with a maximum haplotype association of OR 1.39 (95% CI 1.02-1.89, P= 0.033). This argues that UBAP1 is a novel risk factor for FTLD and likely the gene responsible for linkage to this region. Using antibodies to UBAP1 we have shown this protein co-localises with tau in the neuronal perikaryon in FTLD. Furthermore, UBAP1 interacts with progranulin demonstrated by immunoprecipitation. These data suggest UBAP1 maybe important in regulating the amounts of these proteins via the ubiquitin proteosome system. I propose to identify and functionally characterise the genetic variants driving the UBAP1 association and charterise UBAP1 in human brain and existing mouse models of FTLD. In addition, we have shown that PGRN treatment of primary neurons and glia activates ERK. I propose to investigate the downstream effects of this signalling pathway using microarray analysis and to identify PGRN?s receptor using affinity chromatography. Finally, I will investigate the role of UBAP1 in regulating levels of tau and PGRN using siRNA knockdown and expression of known UBAP1 mutations. This work could provide a paradigm shift in our understanding of the aberrant biological pathways controlling proteins important in FTLD and other neurodegenerative diseases. This work could highlight potential therapeutic targets.</gtr:technicalSummary><gtr:fund><gtr:end>2013-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1491842</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Psychiatry, Psychology &amp; Neuroscience</gtr:department><gtr:description>FUS and FTLD</gtr:description><gtr:id>7A8A0280-C36C-4673-A42D-21A22573420A</gtr:id><gtr:impact>&amp;pound;4.8M Wellcome Trust/MRC neurodegenerative disease collaborative grant</gtr:impact><gtr:outcomeId>BF15777C397-1</gtr:outcomeId><gtr:piContribution>we have contributed in writing a grant to work together on FUS, TDP-43 and progranulin in frontotemporal dementia and motor neuron disease</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute on Aging</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>FTD+ALS chromosome 9 gene hunt</gtr:description><gtr:id>210DE506-8909-4D7F-BBE6-AB2EFDC0DC25</gtr:id><gtr:impact>none yet. 

multi-disciplinary involving geneticists, biochemists, pathologists and neurologists</gtr:impact><gtr:outcomeId>pg9S5rNLFNX-1</gtr:outcomeId><gtr:partnerContribution>They have provided exome sequencing and whole genome genotyping for us</gtr:partnerContribution><gtr:piContribution>we are helping in the identification of the chr9p FTD+ALS gene</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Interview for BBC radio Manchester</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>59A516ED-90AB-4DA9-B172-F70A4F4DC8F4</gtr:id><gtr:impact>Interview on the breakfast show about a grant I was awarded

raised awareness of FTD</gtr:impact><gtr:outcomeId>VkXj7YJqHeb</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk to the public</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>E9FC8A26-A3C6-4DA6-B1AA-238FBE1F0E8E</gtr:id><gtr:impact>As part of World Alzheimer's Day the Alzheimer's Research Trust organised a set of talks to the public about dementia research in Manchester

It was cover by local press raising the awareness to the public of the research we do in Manchester</gtr:impact><gtr:outcomeId>5AD948F3EBA</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>lay talk to public</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>737FB75E-938A-4C6E-8E3F-AFA7CCAC8B71</gtr:id><gtr:impact>I gave a talk to the public about dementia and my research

The Alzheimer's Research Trust who helped organise the event got goos feedback from those who attended</gtr:impact><gtr:outcomeId>DAB6A6FB37C</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>110000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>70EAE7AA-641A-4178-9AC2-6467C1CA17B4</gtr:id><gtr:outcomeId>W4A4Mkc9Wyy</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust/MRC Consortia Grant for Neurodegenerative disease</gtr:description><gtr:end>2015-02-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>E136AE85-229B-4EFC-95B6-36E17389809C</gtr:id><gtr:outcomeId>F3A14E2781F0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>patent to protect the genetic test for the hexanucleotide expansion causing FTD and MND</gtr:description><gtr:grantRef>G0701441</gtr:grantRef><gtr:id>0B97F5CF-21BE-4ACD-A6EF-8B24E8DAC215</gtr:id><gtr:impact>we can now test for the most common genetic cause of MND - mutation is found in 1 out of every 12 patients</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>qHPzZwtYMxC</gtr:outcomeId><gtr:patentId>CT/GB2012/052140</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Identification of the chr9 FTD+MND gene</gtr:title><gtr:yearProtectionGranted>2012</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>we have developed a monoclonal antibody to UBAP1 that is good for neuropathological diagnosis</gtr:description><gtr:id>03DD205B-0AA0-4D5A-BAFF-0EFA5FD5FCC8</gtr:id><gtr:impact>none</gtr:impact><gtr:outcomeId>EADB5B1E1C5</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>UBAP1 monoclonal antibody</gtr:title><gtr:type>Antibody</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>4D2CCB34-BF55-4BA8-A8B9-EE3B9169A49F</gtr:id><gtr:title>Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/510721e2a9e00f86705a3e2bd54d9d27"><gtr:id>510721e2a9e00f86705a3e2bd54d9d27</gtr:id><gtr:otherNames>Yokota O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>A7a7XSR4v3T</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8955903-EEBD-4CDB-B827-703BDD148B17</gtr:id><gtr:title>FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ab9e3dde384013eef79f476bf114e0e9"><gtr:id>ab9e3dde384013eef79f476bf114e0e9</gtr:id><gtr:otherNames>Urwin H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>jQPF3FAM15e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2B3BDC6-BC1F-4323-AEF4-7AE7F869E34F</gtr:id><gtr:title>Frontotemporal dementia with amyotrophic lateral sclerosis: a clinical comparison of patients with and without repeat expansions in C9orf72.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/584f1724437697f2a8de71eef2f411bc"><gtr:id>584f1724437697f2a8de71eef2f411bc</gtr:id><gtr:otherNames>Snowden JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2167-8421</gtr:issn><gtr:outcomeId>pm_15477_27_23421625</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31B2CBE5-F8E9-408A-A0B0-C22A030E83DB</gtr:id><gtr:title>Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e92699e66f262cd182ee6581ab96aae"><gtr:id>5e92699e66f262cd182ee6581ab96aae</gtr:id><gtr:otherNames>H?glinger GU</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>Fg9MbqKGAhj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78BAFBF6-6228-43FE-ADE5-9DDAA6AF498D</gtr:id><gtr:title>Psychosis, C9ORF72 and dementia with Lewy bodies.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/584f1724437697f2a8de71eef2f411bc"><gtr:id>584f1724437697f2a8de71eef2f411bc</gtr:id><gtr:otherNames>Snowden JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_15477_27_22832738</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC8A49BE-DD06-463B-B719-EC7AE8F62DFC</gtr:id><gtr:title>No interaction between tau and TDP-43 pathologies in either frontotemporal lobar degeneration or motor neurone disease.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b25414b7949c1dc388472b22a5fd011"><gtr:id>7b25414b7949c1dc388472b22a5fd011</gtr:id><gtr:otherNames>Robinson AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>5450ec89213933.97909858</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4049ED8F-5609-4EDB-A163-6207F4A7C048</gtr:id><gtr:title>The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/584f1724437697f2a8de71eef2f411bc"><gtr:id>584f1724437697f2a8de71eef2f411bc</gtr:id><gtr:otherNames>Snowden JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>kfgeWmSBDM6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3FB1E03-1D9C-4A7B-B6C1-E80F4DB295C4</gtr:id><gtr:title>Heterogeneous ribonuclear protein E2 (hnRNP E2) is associated with TDP-43-immunoreactive neurites in Semantic Dementia but not with other TDP-43 pathological subtypes of Frontotemporal Lobar Degeneration.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b237e1dd0d5ded53e55bf78ceb3cb1b3"><gtr:id>b237e1dd0d5ded53e55bf78ceb3cb1b3</gtr:id><gtr:otherNames>Davidson YS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>5a2fd39db3a7f4.49699582</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0AFBF92E-FFB0-4789-863D-55EB5767BC10</gtr:id><gtr:title>Pathological correlates of frontotemporal lobar degeneration in the elderly.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7df5df6eb873dcd36d2da09e2f2c5a58"><gtr:id>7df5df6eb873dcd36d2da09e2f2c5a58</gtr:id><gtr:otherNames>Baborie A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>RjCNya18BHo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>290FB32C-B220-4400-9E44-25FCA833F27A</gtr:id><gtr:title>Prominent phenotypic variability associated with mutations in Progranulin.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f7fda1848c9b9033c318769a6d491f2"><gtr:id>6f7fda1848c9b9033c318769a6d491f2</gtr:id><gtr:otherNames>Kelley BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>58bfffeac61d89.81539841</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE4BACCA-B5C1-4F6B-A4DC-A62D6AFE91FE</gtr:id><gtr:title>Recent origin and spread of a common Welsh MAPT splice mutation causing frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Neurogenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b172ff2aa0cc48a159491568c5e89c4a"><gtr:id>b172ff2aa0cc48a159491568c5e89c4a</gtr:id><gtr:otherNames>Colombo R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1364-6745</gtr:issn><gtr:outcomeId>B8172B73487</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48A8E0C5-90C2-480E-A159-229761EC2611</gtr:id><gtr:title>UBAP1 is a component of an endosome-specific ESCRT-I complex that is essential for MVB sorting.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f1509c9cc8ac4a67cd081642e6ee2f2d"><gtr:id>f1509c9cc8ac4a67cd081642e6ee2f2d</gtr:id><gtr:otherNames>Stefani F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn><gtr:outcomeId>5450ec327543b5.10126916</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41081031-BB34-48D0-8513-AB966C254DB4</gtr:id><gtr:title>Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Archives of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d06bc75de7d0ae70212e7e181db73af"><gtr:id>5d06bc75de7d0ae70212e7e181db73af</gtr:id><gtr:otherNames>Chen-Plotkin AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0003-9942</gtr:issn><gtr:outcomeId>QFZThReV2ik</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF6EF4AB-FC33-49B6-A279-D0F5C1709B14</gtr:id><gtr:title>Analysis of optineurin in frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/310bf1b5b3cfcc93127e66670fd761a4"><gtr:id>310bf1b5b3cfcc93127e66670fd761a4</gtr:id><gtr:otherNames>Rollinson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>SWC73YwhXFi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75E75861-14E6-4BE5-9ACE-66558846FDC9</gtr:id><gtr:title>C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32f0eec9d99a9f9c30f1d78b95480322"><gtr:id>32f0eec9d99a9f9c30f1d78b95480322</gtr:id><gtr:otherNames>Mizielinska S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>5450ec8a8fc513.59229766</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D43D23D4-0CFD-4B4A-8CF5-10C581B094E0</gtr:id><gtr:title>TREM2 analysis and increased risk of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9874d781546728b9d27ca4a1610ff582"><gtr:id>9874d781546728b9d27ca4a1610ff582</gtr:id><gtr:otherNames>Finelli D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>5450ec8b33ae81.44364801</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C605CC6B-C422-43B5-9499-74E7A6207644</gtr:id><gtr:title>A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/405062aea31e15048134bff16a4a7b11"><gtr:id>405062aea31e15048134bff16a4a7b11</gtr:id><gtr:otherNames>Renton AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>GDv7L98yJye</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C4A5E57-60A0-41D3-B04A-B484B47C4915</gtr:id><gtr:title>No association of PGRN 3'UTR rs5848 in frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/310bf1b5b3cfcc93127e66670fd761a4"><gtr:id>310bf1b5b3cfcc93127e66670fd761a4</gtr:id><gtr:otherNames>Rollinson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>C43DF46A253</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59FCD6FA-9428-4CE0-8795-D11F6414FB91</gtr:id><gtr:title>Frontotemporal lobar degeneration genome wide association study replication confirms a risk locus shared with amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/310bf1b5b3cfcc93127e66670fd761a4"><gtr:id>310bf1b5b3cfcc93127e66670fd761a4</gtr:id><gtr:otherNames>Rollinson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>nXm8hCNBsyL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4346B7CF-8705-4067-B01F-B36A82D4A596</gtr:id><gtr:title>Small deletion in C9orf72 hides a proportion of expansion carriers in FTLD.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/310bf1b5b3cfcc93127e66670fd761a4"><gtr:id>310bf1b5b3cfcc93127e66670fd761a4</gtr:id><gtr:otherNames>Rollinson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>5675dea59b6ad</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7603B52-01F4-4AA6-82D2-7C24FB181AC9</gtr:id><gtr:title>Ubiquitin associated protein 1 is a risk factor for frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/310bf1b5b3cfcc93127e66670fd761a4"><gtr:id>310bf1b5b3cfcc93127e66670fd761a4</gtr:id><gtr:otherNames>Rollinson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>B2E27CB5DF9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06144C65-3FB6-464C-90C5-104FBE4FF8C4</gtr:id><gtr:title>TDP-43 in ubiquitinated inclusions in the inferior olives in frontotemporal lobar degeneration and in other neurodegenerative diseases: a degenerative process distinct from normal ageing.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd1ac80b42e880cbd4857157a6fb016d"><gtr:id>dd1ac80b42e880cbd4857157a6fb016d</gtr:id><gtr:otherNames>Davidson Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>D6586E09D86</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E718BA9-6802-4266-9B8C-CEE26E469C35</gtr:id><gtr:title>Review: Recent progress in frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9794ad281d069953d2256a1d9ad44d4"><gtr:id>f9794ad281d069953d2256a1d9ad44d4</gtr:id><gtr:otherNames>Pickering-Brown SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>8566CA6FAE2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D1C6585-6F8C-4633-935B-03DD16EC59B1</gtr:id><gtr:title>Semantic dementia associated with corticobasal syndrome: a further variant of frontotemporal lobe degeneration?</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6072d106316caafb6ed0395d27ce6c5b"><gtr:id>6072d106316caafb6ed0395d27ce6c5b</gtr:id><gtr:otherNames>Luzzi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>pm_15477_27_22231872</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BECDFAA2-48A3-4DA3-B7CF-8EB044FBBF28</gtr:id><gtr:title>p62/SQSTM1 analysis in frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4eb4a7e2cf5babdd4f5aeed8e9849645"><gtr:id>4eb4a7e2cf5babdd4f5aeed8e9849645</gtr:id><gtr:otherNames>Miller L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>5675dd248ae68</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE2F37AA-A780-4D8D-BBFA-AF778364FDF1</gtr:id><gtr:title>Chromosome 9 ALS and FTD locus is probably derived from a single founder.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb5ecebb0a95326732850cb51e132dc6"><gtr:id>bb5ecebb0a95326732850cb51e132dc6</gtr:id><gtr:otherNames>Mok K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>5450ec32a57a23.59659948</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8EB6700E-413A-445C-9825-6175B4DE3091</gtr:id><gtr:title>Brain distribution of dipeptide repeat proteins in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b237e1dd0d5ded53e55bf78ceb3cb1b3"><gtr:id>b237e1dd0d5ded53e55bf78ceb3cb1b3</gtr:id><gtr:otherNames>Davidson YS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>5450ec8a055f81.72358986</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5ACF332-B940-4EE7-9A5C-EF99D3ECFEF1</gtr:id><gtr:title>Analysis of the hexanucleotide repeat in C9ORF72 in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/310bf1b5b3cfcc93127e66670fd761a4"><gtr:id>310bf1b5b3cfcc93127e66670fd761a4</gtr:id><gtr:otherNames>Rollinson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_15477_27_22410647</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42D00D6E-40DC-4A16-B522-3DE8C6A272FB</gtr:id><gtr:title>Frontotemporal dementia and its subtypes: a genome-wide association study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9daf1044ffaa78c220fa83b15b9c753"><gtr:id>b9daf1044ffaa78c220fa83b15b9c753</gtr:id><gtr:otherNames>Ferrari R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>5450ec89bb2e10.17540531</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12F9CF6A-E985-4D02-B14A-679C3F25F512</gtr:id><gtr:title>TREM2 variants in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56b2d14505f1916bc463c5643c1c28d8"><gtr:id>56b2d14505f1916bc463c5643c1c28d8</gtr:id><gtr:otherNames>Guerreiro R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>pm_15477_27_23150934</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3270183-241E-42AD-88CD-91C376D6EE68</gtr:id><gtr:title>Dipeptide repeat proteins are present in the p62 positive inclusions in patients with frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb21759b9c84fcbe0a0316dcf50ce9ca"><gtr:id>fb21759b9c84fcbe0a0316dcf50ce9ca</gtr:id><gtr:otherNames>Mann DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>5450ec331f8a76.27092655</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B82B511-00B1-4505-8934-F21E34CDF560</gtr:id><gtr:title>Distinct clinical and pathological phenotypes in frontotemporal dementia associated with MAPT, PGRN and C9orf72 mutations.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/584f1724437697f2a8de71eef2f411bc"><gtr:id>584f1724437697f2a8de71eef2f411bc</gtr:id><gtr:otherNames>Snowden JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2167-8421</gtr:issn><gtr:outcomeId>585d56b2627b39.10989848</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E1D528F-F615-4AF1-AC7E-63F4E969820E</gtr:id><gtr:title>Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/584f1724437697f2a8de71eef2f411bc"><gtr:id>584f1724437697f2a8de71eef2f411bc</gtr:id><gtr:otherNames>Snowden JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_15477_27_22300873</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68633A75-0037-446B-9504-FE4C179E29F6</gtr:id><gtr:title>Prominent sensorimotor neuropathy due to SACS mutations revealed by whole-exome sequencing.</gtr:title><gtr:parentPublicationTitle>Archives of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6aec7e888ca27cb54fb6a199e4662974"><gtr:id>6aec7e888ca27cb54fb6a199e4662974</gtr:id><gtr:otherNames>Pyle A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0003-9942</gtr:issn><gtr:outcomeId>pm_15477_27_22751902</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FEF95BFE-3AB7-4837-80DB-81979DF823E1</gtr:id><gtr:title>Next generation sequencing of CLU, PICALM and CR1: pitfalls and potential solutions.</gtr:title><gtr:parentPublicationTitle>International journal of molecular epidemiology and genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4b8e9376e1c9c6dd0767c0dbe1f9f575"><gtr:id>4b8e9376e1c9c6dd0767c0dbe1f9f575</gtr:id><gtr:otherNames>Lord J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1948-1756</gtr:issn><gtr:outcomeId>pm_15477_27_23205178</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B350861C-A43E-41F2-B061-9332DBD5AC6C</gtr:id><gtr:title>Effect of topographical distribution of a-synuclein pathology on TDP-43 accumulation in Lewy body disease.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/510721e2a9e00f86705a3e2bd54d9d27"><gtr:id>510721e2a9e00f86705a3e2bd54d9d27</gtr:id><gtr:otherNames>Yokota O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>n1ZTChFptKQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>061FA0FC-A8A7-4055-A9AE-B83C0A008AD2</gtr:id><gtr:title>Pathogenesis/genetics of frontotemporal dementia and how it relates to ALS.</gtr:title><gtr:parentPublicationTitle>Experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75a3f3f4dfd1cc870160b14f140be0d7"><gtr:id>75a3f3f4dfd1cc870160b14f140be0d7</gtr:id><gtr:otherNames>Bennion Callister J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0014-4886</gtr:issn><gtr:outcomeId>5450ec8981b746.91780425</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A02308BF-E8DE-4DA2-B4B8-7135C01331F6</gtr:id><gtr:title>Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9ff70460a8a25a64715383958cc1a82"><gtr:id>a9ff70460a8a25a64715383958cc1a82</gtr:id><gtr:otherNames>Majounie E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>pm_15477_27_22406228</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4756B7F4-D1EF-45FB-B89D-DF1759BDDCA1</gtr:id><gtr:title>Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80d90ee46f35a4a33c5823afc4f87b66"><gtr:id>80d90ee46f35a4a33c5823afc4f87b66</gtr:id><gtr:otherNames>Van Deerlin VM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>Hmbnm9traDk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E58BAAD9-A8AB-493A-A43E-9F5F4EA7A698</gtr:id><gtr:title>TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b237e1dd0d5ded53e55bf78ceb3cb1b3"><gtr:id>b237e1dd0d5ded53e55bf78ceb3cb1b3</gtr:id><gtr:otherNames>Davidson YS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>kYMmEGaENpW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2FD79BBE-8A02-4266-AC27-61DCAF3E45D0</gtr:id><gtr:title>Psychosis associated with expansions in the C9orf72 gene: the influence of a 10 base pair gene deletion.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/584f1724437697f2a8de71eef2f411bc"><gtr:id>584f1724437697f2a8de71eef2f411bc</gtr:id><gtr:otherNames>Snowden JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>585d58e1290836.19072758</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0701441</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>